Logo image of ASG.CA

AURORA SPINE CORP (ASG.CA) Stock Fundamental Analysis

TSX-V:ASG - TSX Venture Exchange - CA05206X1087 - Common Stock - Currency: CAD

0.31  0 (0%)

Fundamental Rating

3

Taking everything into account, ASG scores 3 out of 10 in our fundamental rating. ASG was compared to 2 industry peers in the Health Care Equipment & Supplies industry. ASG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ASG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ASG had negative earnings in the past year.
In the past year ASG had a positive cash flow from operations.
In the past 5 years ASG always reported negative net income.
In multiple years ASG reported negative operating cash flow during the last 5 years.
ASG.CA Yearly Net Income VS EBIT VS OCF VS FCFASG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

ASG has a better Return On Assets (-9.23%) than 92.86% of its industry peers.
Looking at the Return On Equity, with a value of -26.29%, ASG belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
Industry RankSector Rank
ROA -9.23%
ROE -26.29%
ROIC N/A
ROA(3y)-12.48%
ROA(5y)-12.6%
ROE(3y)-29.77%
ROE(5y)-27.75%
ROIC(3y)N/A
ROIC(5y)N/A
ASG.CA Yearly ROA, ROE, ROICASG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

ASG has a Gross Margin of 59.63%. This is in the better half of the industry: ASG outperforms 64.29% of its industry peers.
ASG's Gross Margin has improved in the last couple of years.
ASG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.72%
GM growth 5Y13.74%
ASG.CA Yearly Profit, Operating, Gross MarginsASG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

More info and screens

5

2. Health

2.1 Basic Checks

ASG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ASG has more shares outstanding
Compared to 5 years ago, ASG has more shares outstanding
Compared to 1 year ago, ASG has a worse debt to assets ratio.
ASG.CA Yearly Shares OutstandingASG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ASG.CA Yearly Total Debt VS Total AssetsASG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of 0.35, we must say that ASG is in the distress zone and has some risk of bankruptcy.
ASG has a Altman-Z score of 0.35. This is in the better half of the industry: ASG outperforms 78.57% of its industry peers.
The Debt to FCF ratio of ASG is 14.76, which is on the high side as it means it would take ASG, 14.76 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 14.76, ASG belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
A Debt/Equity ratio of 0.81 indicates that ASG is somewhat dependend on debt financing.
ASG has a Debt to Equity ratio (0.81) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 14.76
Altman-Z 0.35
ROIC/WACCN/A
WACC6.87%
ASG.CA Yearly LT Debt VS Equity VS FCFASG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

ASG has a Current Ratio of 2.02. This indicates that ASG is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ASG (2.02) is better than 71.43% of its industry peers.
A Quick Ratio of 1.13 indicates that ASG should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.13, ASG is doing good in the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.13
ASG.CA Yearly Current Assets VS Current LiabilitesASG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.79% over the past year.
ASG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.34%.
The Revenue has been growing by 9.51% on average over the past years. This is quite good.
EPS 1Y (TTM)21.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)15.34%
Revenue growth 3Y18.54%
Revenue growth 5Y9.51%
Sales Q2Q%10.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASG.CA Yearly Revenue VS EstimatesASG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ASG.CA Yearly EPS VS EstimatesASG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ASG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASG.CA Price Earnings VS Forward Price EarningsASG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ASG is valued cheaper than 85.71% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ASG is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 70.84
EV/EBITDA 82.81
ASG.CA Per share dataASG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ASG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AURORA SPINE CORP

TSX-V:ASG (6/13/2025, 7:00:00 PM)

0.31

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-22 2025-05-22
Earnings (Next)08-19 2025-08-19
Inst Owners0%
Inst Owner ChangeN/A
Ins Owners25.16%
Ins Owner ChangeN/A
Market Cap23.94M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.98
P/FCF 70.84
P/OCF 20.35
P/B 4.27
P/tB 5.28
EV/EBITDA 82.81
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY1.41%
OCF(TTM)0.02
OCFY4.91%
SpS0.32
BVpS0.07
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.23%
ROE -26.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.63%
FCFM 1.39%
ROA(3y)-12.48%
ROA(5y)-12.6%
ROE(3y)-29.77%
ROE(5y)-27.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.72%
GM growth 5Y13.74%
F-Score5
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 14.76
Debt/EBITDA 13.36
Cap/Depr 63.34%
Cap/Sales 3.44%
Interest Coverage N/A
Cash Conversion 344.63%
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 1.13
Altman-Z 0.35
F-Score5
WACC6.87%
ROIC/WACCN/A
Cap/Depr(3y)69.84%
Cap/Depr(5y)82.94%
Cap/Sales(3y)4.27%
Cap/Sales(5y)5.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.34%
Revenue growth 3Y18.54%
Revenue growth 5Y9.51%
Sales Q2Q%10.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y116.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y223.29%
OCF growth 3YN/A
OCF growth 5Y319.03%